These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 8383171)

  • 21. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI; Wang F; Kieff E
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
    J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C; Howe JG; Speck SH; Miller G
    J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
    Gahn TA; Sugden B
    J Virol; 1993 Nov; 67(11):6379-86. PubMed ID: 8411339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
    Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
    Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
    Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
    Roth G; Curiel T; Lacy J
    Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
    Hu LF; Minarovits J; Cao SL; Contreras-Salazar B; Rymo L; Falk K; Klein G; Ernberg I
    J Virol; 1991 Mar; 65(3):1558-67. PubMed ID: 1847471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.